Effect of Vidangadi Guggul comapre with Dhatri Nishe in Madhumeha (Type II Diabetes Mellitus)

Randomized Controlled Trial of Vidangadi Guggul compare with Dhatri Nishe in Madhumeha with special reference to Type II Diabetes Mellitus.

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048454

Enrollment

Registered

2022-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are willing to participate in trial and ready to give written consent. 2. Patients of type II DM of 30 to 70 years of age, irrespective of sex. 3. Newly detected patients as well as the patient who are not responding to any oral hypoglycemic agents and blood sugar level is as below of type II DM. 4. Patients with fasting blood sugar ranges from 110-200 mg/dl and post prandial blood sugar ranges from 180-250 mg/dl, with clinical signs and symptoms of Madhumeha. 5. Glycosylated hemoglobin (HbA1C) range 6.5 % - 10%. 6. Patient who are diagnosed in routine check-up or present with other complaints in the hospital. 7. Patient who has not participated in any research project in last 6 months. 8. Patient with controlled hypertension i.e., systolic blood pressure upto140 mm of Hg while diastolic blood pressure up to 100 mm of Hg.

Exclusion criteria

Exclusion criteria: 1. Patients having fasting blood sugar level >200mg/dl and post meal blood sugar level >250 mg/dl. 2. Patients who are not willing to participate in trial and not ready to give written consent. 3. Patients having age below 30 and above 70 years. 4. Pregnant women and lactating mothers. 5. Acute complications of hyperglycemia like DKA (Diabetic Ketoacidosis). 6. Type 1 DM, Gestational DM and patient on insulin therapy. 7. Patients suffering from the serious macrovascular and microvascular complications of DM. 8. Patients suffering from any other serious systemic diseases. 9. Diabetes Mellitus developed due to secondary causes such as infective pancreatitis, autoimmune pathology etc.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Vidangadi Guggul in management of Madhumeha on Blood sugar level with special reference to type II diabetes mellitus in a period of 60 days. 2. To compare the effect of Dhatri Nishe Vati in management of Madhumeha with special reference to type II DM.Timepoint: 18 months	—

Secondary

Measure	Time frame
To study the literature of Madhumeha in detail as per Ayurvedic classics. 2. To study the literature of Diabetes MellitusTimepoint: 60 days	—

Countries

India

Contacts

Public ContactKamal Gangaram Tawade

Government Ayurved College and HospitalNagpur

sushilvilaschawre@gmail.com9834625938

Outcome results